Nutritional supplements: Prevalence of use and contamination with doping agents

Nutrition Research Reviews

Volumn 19, Issue 1, 2006, Pages 147-158

  Van Thuyne, W ^a   Van Eenoo, P ^a   Delbeke, F T ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Doping; Nutritional supplements; Prohormones; Stimulants

Indexed keywords

ANABOLIC AGENT; CENTRAL STIMULANT AGENT; CODEINE; EPHEDRINE; HERBACEOUS AGENT; HORMONE PRECURSOR; MINERAL; MORPHINE; NANDROLONE; NARCOTIC AGENT; NORCODEINE; PAPAVERINE; TESTOSTERONE; THEBAINE; VITAMIN;

ATHLETE; DIET SUPPLEMENTATION; DOPING; DRUG CONTAMINATION; DRUG MARKETING; EPHEDRA; HEALTH HAZARD; HORMONE STRUCTURE; HUMAN; LIFESTYLE; NUTRITION; NUTRITIONAL ASSESSMENT; PREVALENCE; REVIEW; VITAMIN SUPPLEMENTATION; WEIGHT REDUCTION;

EPHEDRA;

EID: 33746844092     PISSN: 09544224     EISSN: None     Source Type: Journal    
DOI: 10.1079/NRR2006122     Document Type: Review

References (115)

1. Abourashed EA, El-Alfy AT, Khan IA & Walker L (2003) Ephedra in perspective - a current review. Phytotherapy Research 17, 703-712.
2. Barkan S, Weber JD & Smith E (1981) Determination of cross-contamination of the dia-stereomers ephedrine and pseudoephedrine by high-performance liquid-chromatography, thin-layer chromatography and C-13 nuclear magnetic-resonance spectroscopy. Journal of Chromatography 219, 81-88.
3. Bell A, Dorsch KD, McCreary DR & Hovey R (2004) A look at nutritional supplement use in adolescents. Journal of Adolescent Health 34, 508-516.
4. Bell DG & Jacobs I (1999) Combined caffeine and ephedrine ingestion improves run times of Canadian Forces Warrior Test. Aviation Space and Environmental Medicine 70, 325-329.
5. Bell DG, Jacobs I & Ellerington K (2001) Effect of caffeine and ephedrine ingestion on anaerobic exercise performance. Medicine and Science in Sports and Exercise 33, 1399-1403.
6. Bell DG, Jacobs I, McLellan TM & Zamecnik J (2000) Reducing the dose of combined caffeine and ephedrine preserves the ergogenic effect. Aviation Space and Environmental Medicine 71, 415-419.
7. Bell DG, Jacobs I & Zamecnik J (1998) Effects of caffeine, ephedrine and their combination on time to exhaustion during high-intensity exercise. European Journal of Applied Physiology and Occupational Physiology 77, 427-433.
8. Bents RT, Tokish JM & Goldberg L (2004) Ephedrine, pseudoephedrine, and amphetamine prevalence in college hockey players - most report performance-enhancing use. Physician and Sportsmedicine 32, 30-34.
9. Benzi G (2000) Is there a rationale for the use of creatine either as nutritional supplementation or drug administration in humans participating in a sport? Pharmacological Research 41, 255-264.
10. Beshgetoor D & Nichols JF (2003) Dietary intake and supplement use in female master cyclists and runners. International Journal of Sport Nutrition and Exercise Metabolism 13, 166-172.
11. Betz JM, Gay ML, Mossoba MM, Adams S & Portz BS (1997) Chiral gas chromatographic determination of ephedrine-type alkaloids in dietary supplements containing Ma Huang. Journal of AOAC International 80, 303-315.
12. Boozer CN, Daly PA, Homel P, Solomon JL, Blanchard D, Nasser JA, Strauss R & Meredith T (2002) Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial. International Journal of Obesity 26, 593-604.
13. Broeder CE (2003) Oral andro-related prohormone supplementation: do the potential risks outweigh the benefits? Canadian Journal of Applied Physiology 28, 102-116.
14. Breeder CE, Quindry J, Brittingham K, Panton L, Thomson J, Appakondu S, Breuel K, Byrd R, Douglas J, Earnest C, et al. (2000) The andro project - physiological and hormonal influences of androstenedione supplementation in men 35 to 65 years old participating in a high-intensity resistance training program. Archives of Internal Medicine 160, 3093-3104.
15. Brown GA, Vukovich MD, Reifenrath TA, Uhl NL, Parsons KA, Sharp RL & King DS (2000) Effects of anabolic precursors on serum testosterone concentrations and adaptations to resistance training in young men. International Journal of Sport Nutrition and Exercise Metabolism 10, 340-359.
16. Canter PH & Ernst E (2004) Herbal supplement use by persons aged over 50 years in Britain - frequently used herbs, concomitant use of herbs, nutritional supplements and prescription drugs, rate of informing doctors and potential for negative interactions. Drugs and Aging 21, 597-605.
17. Catlin DH, Leder BZ, Ahrens B, Starcevic B, Hatton CK, Green GA & Finkelstein JS (2000) Trace contamination of over-the-counter androstenedione and positive urine test results for a nandrolone metabolite. Journal of the American Medical Association 284, 2618-2621.
18. Chen KK & Schmidt CF (1926) The action and clinical use of ephedrine. Journal of the American Pharmaceutical Association 87, 836-842.
19. Chester N, Reilly T & Mottram DR (2003) Physiological, subjective and performance effects of pseudoephedrine and phenylpropanolamine during endurance running exercise. International Journal of Sports Medicine 24, 3-8.
20. Chu KS, Doherty TJ, Parise G, Milheiro JS & Tarnopolsky MA (2002) A moderate dose of pseudoephedrine does not alter muscle contraction strength or anaerobic power. Clinical Journal of Sports Medicine 12, 387-390.
21. Corrigan B & Kazlauskas R (2003) Medication use in athletes selected for doping control at the Sydney Olympics (2000). Clinical Journal of Sport Medicine 13, 33-40.
22. Coutts RT, Dawe R, Jones GR, Liu SF & Midha KK (1980) Analysis of perfluoroacyl derivatives of ephedrine, pseudoephedrine and analogues by gas-chromatography and mass-spectrometry. 1. Trifluoroacetyl derivatives. Journal of Chromatography 190, 53-65.
23. Davies AM (1997) Survey of caffeine and other methylxanthines in energy drinks and other caffeine-containing products. Food Surveillance 103, 1-18.
24. De Cock KJS, Delbeke FT, Van Eenoo P, Desmet N, Roels K & De Backer P (2001) Detection and determination of anabolic steroids in nutritional supplements. Journal of Pharmaceutical and Biomedical Analysis 25, 843-852.
25. Delbeke FT (2001) Nutritional supplements and doping. In Biomedical Side Effects of Doping, pp. 155-161 [C Peters, T Schulz and H Michna, editors]. Cologne: Sport and Buch Strauß.
26. Delbeke FT, Van Eenoo P, Van Thuyne W & Desmet N (2002) Prohormones and sport. Journal of Steroid Biochemistry and Molecular Biology 83, 245-251.
27. Doherty M (1998) The effects of caffeine on the maximal accumulated oxygen deficit and short-term running performance. International Journal of Sport Nutrition 8, 95-104.
28. Dutt MC & Poh TT (1981) Identification of basic drugs by the thin-layer chromatographic profiles of their ninhydrin complexes. Journal of Chromatography 206, 267-277.
29. Elsohly HN, Stanford DF, Jones AB, Elsohly MA, Snyder H & Pedersen C (1988) Gas-chromatographic mass-spectrometric analysis of morphine and codeine in human urine of poppy seed eaters. Journal of Forensic Sciences 33, 347-356.
30. Engelhardt M, Neumann G, Berbalk A & Reuter I (1998) Creatine supplementation in endurance sports. Medicine and Science in Sports and Exercise 30, 1123-1129.
31. Flurer CL, Lin LA, Satzger RD & Wolnik KA (1995) Determination of ephedrine compounds in nutritional supplements by cyclodextrin-modified capillary electrophoresis. Journal of Chromatography 669B, 133-139.
32. Food and Drug Administration (1994) Dietary Supplement Health and Education Act of 1994, Public Law 103-417, 103rd Congress, 2nd session, S784. Accessed 25 January 2005. http:// www.fda.gov/opacom/laws/dshea.html
33. Food and Drug Administration (2004) Center for Food Safety and Applied Nutritional. Dietary Supplements: ephedrine alkaloids. Accessed 10 January 2005. http://www.cfsan.fda.gov/~dms. ds-ephed.html
34. Gal J (1984) Resolution of the enantiomers of ephedrine, norephedrine and pseudoephedrine by high-performance liquid-chromatography. Journal of Chromatography 307, 220-223.
35. Geisendorfer T & Gmeiner G (2003) Analysis of nutritional supplements using gel-permeation as clean up step. In Recent Advances in Doping Analysis, pp. 373-376 [W Schänzer, H Geyer, A Gotzmann and U Mareck, editors]. Cologne: Sport and Buch Strauß.
36. Geyer H, Bredehöft M, Mareck U, Parr MK & Schänzer W (2002) Hoge dosen des anabolikums metandienon in nahrungsergänzungsmitteln gefunden (High doses of the anabolic steroid methandienone found in nutritional supplements). Deutsche Apotheker Zeitung 142, 50.
37. Geyer H, Mareck-Engelke U, Reinhart U, Thevis M & Schänzer W (2000) Positive Dopingfälle mit Norandrosteron durch Verunreinigte Nahrungsergänzungsmittel (Positive doping cases with norandrosterone after application of contaminated nutritional supplements). Deutsche Zeitschrift für Sportmedizin 51, 378-382.
38. Geyer H, Parr MK, Mareck U, Reinhart U, Schrader Y & Schänzer W (2004) Analysis of non-hormonal nutritional supplements for anabolic-androgenic steroids - results of an international study. International Journal of Sports Medicine 25, 124-129.
39. Gill ND, Shield A, Blazevich AJ, Zhou S & Weatherby RP (2000) Muscular and cardiorespiratory effects of pseudoephedrine in human athletes. British Journal of Clinical Pharmacology 50, 205-213.
40. Gillies H, Derman WE, Noakes TD, Smith P, Evans A & Gabriels G (1996) Pseudoephedrine is without ergogenic effects during prolonged exercise. Journal of Applied Physiology 81, 2611-2617.
41. Gmeiner G (2002) Methandienon in sportnahrung (Methandienone in sports nutrition). Osterreichische Journal fur Sportmedizin 2, 33-34.
42. Graham TE, Hibbert E & Sathasivam P (1998) Metabolic and exercise endurance effects of coffee and caffeine ingestion. Journal of Applied Physiology 85, 883-889.
43. Green GA, Catlin TH & Starcevic B (2001) Analysis of over-the-counter dietary supplements. Clinical Journal of Sport Medicine 11, 254-259.
44. Gurley BJ, Gardner SF & Hubbard MA (2000) Content versus label claims in Ephedra-containing dietary supplements. American Journal of Health-System Pharmacy 57, 963-969.
45. Gurley BJ, Wang P & Gardner SF (1998) Ephedrine-type alkaloid content of nutritional supplements containing Ephedra sinica (Ma-Huang) as determined by high performance liquid chromatography. Journal of Pharmaceutical Sciences 87, 1547-1553.
46. Habscheid W, Abele U & Dahm HH (1999) Anabolic steroids as a cause of severe cholestasis and renal failure in a body builder. Deutsche Medizinische Wochenschrift 124, 1029-1032.
47. Haller CA & Benowitz NL (2000) Adverse cardiovascular and central nervous system events associated with dietary supplements containing Ephedra alkaloids. New England Journal of Medicine 343, 1833-1838.
48. Haller CA, Duan MJ, Benowitz NL & Jacob P (2004a) Concentrations of Ephedra alkaloids and caffeine in commercial dietary supplements. Journal of Analytical Toxicology 28, 145-151.
49. Haller CA, Jacob P & Benowitz NL (2004e) Enhanced stimulant and metabolic effects of combined ephedrine and caffeine. Clinical Pharmacology and Therapeutics 75, 259-273.
50. Hansen LB (2001) A stable gas chromatography-mass spectrometry analysis system to characterize Ma Huang products found in health foods and supplements. Journal of Pharmaceutical Sciences 90, 943-948.
51. Hayes LW, Krasselt WG & Mueggler PA (1987) Concentrations of morphine and codeine in serum and urine after ingestion of poppy seeds. Clinical Chemistry 33, 806-808.
52. Hioki C, Yoshimoto K & Yoshida T (2004) Efficacy of Bofutsusho-san, an oriental herbal medicine, in obese Japanese women with impaired glucose tolerance. Clinical and Experimental Pharmacology and Physiology 31, 614-619.
53. Hodges ANH, Lynn BM, Bula JE, Donaldson MG, Dagenais MO & McKenzie DC (2003) Effects of pseudoephedrine on maximal cycling power and submaximal cycling efficiency. Medicine and Science in Sports and Exercise 35, 1316-1319.
54. Hurlbut JA, Carr JR, Singleton ER, Faul KC, Madson MR, Storey JM & Thomas TL (1998) Solid-phase extraction cleanup and liquid chromatography with ultraviolet detection of ephedrine alkaloids in herbal products. Journal of AOAC International 81, 1121-1127.
55. Imaz C, Carreras D, Navajas R, Rodriguez C, Rodriguez AF, Maynar J & Cortes R (1993) Determination of ephedrines in urine by high-performance liquid-chromatography. Journal of Chromatography 631, 201-205.
56. Imaz C, Navajas R, Carreras D, Rodriguez C & Rodriguez AF (2000) Comparison of various reversed-phase columns for the simultaneous determination of ephedrines in urine by high-performance liquid chromatography. Journal of Chromatography 870A, 23-28.
57. Jacob P, Haller CA, Duan MJ, Yu L, Peng M & Benowitz NL (2004) Determination of Ephedra alkaloid and caffeine concentrations in dietary supplements and biological fluids. Journal of Analytical Toxicology 28, 152-159.
58. Jacobs I, Pasternak H & Bell DG (2003) Effects of ephedrine, caffeine, and their combination on muscular endurance. Medicine and Science in Sports and Exercise 35, 987-994.
59. Kamber M, Baume N, Saugy M & Rivier L (2001) Nutritional supplements as a source for positive doping cases? International Journal of Sport Nutrition and Exercise Metabolism 11, 258-263.
60. Konig WA & Ernst K (1983) Application of enantioselective capillary gas-chromatography to the analysis of chiral pharmaceuticals. Journal of Chromatography 280, 135-141.
61. Kovacs EMR, Stegen JHCH & Brouns F (1998) Effect of caffeinated drinks on substrate metabolism, caffeine excretion, and performance. Journal of Applied Physiology 85, 709-715.
62. Kreider RB (1999) Dietary supplements and the promotion of muscle growth with resistance exercise. Sports Medicine 27, 97-110.
63. Leder BZ, Longcope C, Catlin DH, Ahrens B, Schoenfeld DA & Finkelstein JS (2000) Oral androstenedione administration and serum testosterone concentrations in young men. Journal of the American Medical Association 283, 779-782.
64. Li HX, Ding MY, Lv K & Yu JY (2002) Simultaneous separation and determination of ephedrine alkaloids and tetramethylpyrazine in Ephedra sinica Stapf by HPLC. Journal of Liquid Chromatography and Related Technologies 25, 313-320.
65. Lo DST & Chua TH (1992) Poppy seeds - implications of consumption. Medicine Science and the Law 32, 296-302.
66. Macintosh BR & Wright BM (1995) Caffeine ingestion and performance of a 1,500-meter swim. Canadian Journal of Applied Physiology 20, 168-177.
67. Manore MM, Barr SI & Butterfield GE (2000) Position of dietitians of Canada, the American Dietetic Association, and the American College of Sports Medicine: nutrition and athletic performance. Canadian Journal of Dietetic Practice and Research 61, 176-192.
68. Maughan R (2002) The scope of nutritional supplement use in sport. In Health and Doping Risks of Nutritional Supplements and Social Drugs, pp. 7-9 [W Schänzer, H Geyer, A Gotzmann and U Mareck-Engelke, editors]. Cologne: Sport and Buch Strauß.
69. Maughan RJ, King DS & Lea T (2004) Dietary supplements. Journal of Sport Sciences 22, 95-113.
70. Meadway C, George S & Braithwaite R (1998) Opiate concentrations following the ingestion of poppy seed products - evidence for 'the poppy seed defence'. Forensic Science International 96, 29-38.
71. Morrison LJ, Gizis F & Shorter B (2004) Prevalent use of dietary supplements among people who exercise at a commercial gym. International Journal of Sport Nutrition and Exercise Metabolism 14, 481-492.
72. Mottram DR & George AJ (2000) Anabolic steroids. Baillière's Best Practice and Research. Clinical Endocrinology and Metabolism 14, 55-69.
73. Mujika I, Chatard J, Lacoste L, Barale F & Geyssant A (1996) Creatine supplementation does not improve sprint performance in competitive swimmers. Medicine and Science in Sports and Exercise 28, 1435-1441.
74. Müller RK & Müller-Platz C (2001) Aggression and anabolic steroid hormones: do anabolic androgenic steroids enhance aggressiveness? In Biomedical Side Effects of Doping, pp. 107-114 [C Peters, T Schulz and H Michna, editors]. Cologne: Sport and Buch Strauß.
75. Nieman DC, Gates JR, Butler JV, Dietrich SJ & Lutz RD (1989) Supplementation patterns in marathon runners. Journal of the American Dietetic Association 89, 1615-1619.
76. Okamura N, Miki H, Harada T, Yamashita S, Masaoka Y, Nakamoto Y, Tsuguma M, Yoshitomi H & Yagi A (1999) Simultaneous determination of ephedrine, pseudoephedrine, norephedrine and methylephedrine in Kampo medicines by high-performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis 20, 363-372.
77. Parr MK, Geyer H, Reinhart U & Schanzer W (2004) Analytical strategies for the detection of non-labelled anabolic androgenic steroids in nutritional supplements. Food Additives and Contaminants 21, 632-640.
78. Parr MK, Geyer H, Sigmund G, Köhler K & Schänzer W (2003) Screening of nutritional supplements for stimulants and other drugs. In Recent Advances in Doping Analysis, pp. 67-75 [W Schänzer, H Geyer, A Gotzmann and U Mareck, editors]. Cologne: Sport and Buch Strauß.
79. Parssinen M & Seppala T (2002) Steroid use and long-term health risks in former athletes. Sports Medicine 32, 83-94.
80. Perko M, Bartee RT, Dunn MS, Wang MQ & Eddy J (2000) Giving new meaning to the term "taking one for the team": influences on the use/non-use of dietary supplements among adolescent athletes. American Journal of Health Studies 16, 99-106.
81. Powers ME (2001) Ephedra and its application to sport performance: another concern for the athletic trainer? Journal of Athletic Training 36, 420-424.
82. Rasmussen BB, Volpi E, Gore DC & Wolfe RR (2000) Androstenedione does not stimulate muscle protein anabolism in young healthy men. Journal of Clinical Endocrinology and Metabolism 85, 55-59.
83. Roman MC & Walther HJ (2004) Determination of ephedrine alkaloids in botanicals and dietary supplements by HPLC-UV: collaborative study. Journal of AOAC International 87, 1-14.
84. Ronsen O, Sundgot-Borgen J & Maehlum S (1999) Supplement use and nutritional habits in Norwegian elite athletes. Scandinavian Journal of Medicine and Science in Sports 9, 28-35.
85. Ros JJW, Pelders MG & De Smet PAGM (1999) A case of positive doping associated with a botanical food supplement. Pharmacy World and Science 21, 44-46.
86. Schroder H, Navarro E, Mora J, Seco J, Torregrosa JM & Tramullas A (2002) The type, amount, frequency and timing of dietary supplement use by elite players in the First Spanish Basketball League. Journal of Sports Sciences 20, 353-358.
87. Schröder U (2002) Health effects of nutritional supplements. In Health and Doping Risks of Nutritional Supplements and Social Drugs, pp. 11-15 [W Schänzer, FT Delbeke, A Deligiannis, G Gmeiner, R Maughan and J Mester, editors]. Cologne: Sport and Buch Strauß.
88. Schwenk TL & Costley CD (2002) When food becomes a drug: nonanabolic nutritional supplement use in athletes. American Journal of Sports Medicine 30, 907-916.
89. Sekera MH, Ahrens BD, Chang YC, Starcevic B, Georgakopoulos C & Catlin DH (2005) Another designer steroid: discovery, synthesis, and detection of 'madol' in urine. Rapid Communications in Mass Spectrometry 19, 781-784.
90. Selavka CM (1991) Poppy seed ingestion as a contributing factor to opiate-positive urinalysis results - the Pacific perspective. Journal of Forensic Sciences 36, 685-696.
91. Shekelle PG, Hardy ML, Morton SC, Maglione M, Mojica WA, Suttorp MJ, Rhodes SL, Jungvig L & Gagne J (2003) Efficacy and safety of Ephedra and ephedrine for weight loss and athletic performance - a meta-analysis. Journal of the American Medical Association 289, 1537-1545.
92. Sinclair CJD & Geiger JD (2000) Caffeine use in sports - a pharmacological review. Journal of Sports Medicine and Physical Fitness 40, 71-79.
93. Sobal J & Marquart LF (1994a) Vitamin mineral supplement use among athletes - a review of the literature. International Journal of Sport Nutrition 4, 320-334.
94. Sobal J & Marquart LF (1994b) Vitamin mineral supplement use among high-school athletes. Adolescence 29, 835-843.
95. Sundgot-Borgen J, Berglund B & Torstveit MK (2003) Nutritional supplements in Norwegian elite athletes - impact of international ranking and advisors. Scandinavian Journal of Medicine and Science in Sports 13, 138-144.
96. Talalay P (2001) The importance of using scientific principles in the development of medicinal agents from plants. Academic Medicine 76, 238-247.
97. Trujillo WA & Sorenson WR (2003) Determination of ephedrine alkaloids in dietary supplements and botanicals by liquid chromatography/tandem mass spectrometry: collaborative study. Journal of AOAC International 86, 657-668.
98. Uralets VP & Gillette PA (1999) Over-the-counter anabolic steroids 3-androsten-3,17-dione; 4-androsten-3 beta, 17 beta-diol; and 19-nor-4-androsten-3,17-dione: excretion studies in men. Journal of Analytical Toxicology 23, 357-366.
99. Uralets VP & Gillette PA (2000) Over-the-counter delta(5) anabolic steroids 5-androsten-3,17-dione; 5-androsten-3 beta, 17 beta-diol; dehydroepiandrosterone; and 19-nor-5-androsten-3,17-dione: excretion studies in men. Journal of Analytical Toxicology 24, 188-193.
100. Vandermerwe PJ, Brown LW & Hendrikz SE (1994) Simultaneous quantification of ephedrines in urine by high performance liquid-chromatography. Journal of Chromatography 661B, 357-361.
101. Vandermerwe PJ & Hendrikz SE (1995) Identification of ephedrines as their carbon-disulfide derivatives. Journal of Chromatography 663B, 160-166.
102. Van Eenoo P, Delbeke FT, Desmet N & De Backer P (1998) Excretion studies with 4-androstene-3,17-dione. In Recent Advances in Doping Analysis, pp. 171-180 [W Schänzer, H Geyer, A Gotzmann and U Mareck-Engelke, editors]. Cologne: Sport and Buch Strauß.
103. Van Eenoo P, Delbeke FT, Desmet N & De Backer P (2000) Excretion studies with Tribulus terrestris. In Recent Advances in Doping Analysis, pp. 13-22 [W Schänzer, H Geyer, A Gotzmann and U Mareck-Engelke, editors]. Cologne: Sport and Buch Strauß.
104. Van Eenoo P, Delbeke FT, Roels K & De Backer P (2001) Simultaneous quantitation of ephedrines in urine by gas chromatography-nitrogen-phosphorus detection for doping control purposes. Journal of Chromatography 760B, 255-261.
105. Van Thuyne W & Delbeke FT (2004) Validation of a GC-MS screening method for anabolizing agents in solid nutritional supplements. Biomedical Chromatography 18, 155-159.
106. Van Thuyne W & Delbeke FT (2005) Validation of a GC-MS screening method for anabolizing agents in aqueous nutritional supplements. Journal of Chromatographic Science 43, 2-6.
107. Van Thuyne W, Van Eenoo P & Delbeke FT (2003) Urinary concentrations of morphine after the administration of herbal teas containing Papaveris fructus in relation to doping analysis. Journal of Chromatography 785B, 245-251.
108. Van Thuyne W, Van Eenoo P, Mikulcíková P, Deventer K & Delbeke FT (2005) Detection of androst-4-ene-3,6,17-trione (6-OXO®) and its metabolites in urine by gas chromatography-mass spectrometry in relation to doping analysis. Biomedical Chromatography 19, 689-695.
109. Volek JS, Kraemer WJ, Bush JA, Boetes M, Incledon T, Clark KL & Lynch JM (1997) Creatine supplementation enhances muscular performance during high-intensity resistance exercise. Journal of the American Dietetic Association 97, 765-770.
110. Wadler GI & Hainline B (1989) Anabolic steroids: adverse effects. In Drugs and the Athlete, pp. 55-66 [AJ Ryan, editor]. Philadelphia, PA: FA Davis Company.
111. Wainer IW, Doyle TD, Fry FS & Hamidzadeh Z (1986) Chiral recognition model for the resolution of ephedrine and related alpha-aminoalcohol, beta-aminoalcohol as enantiomeric oxazolidine derivatives. Journal of Chromatography 355, 149-156.
112. Wiedemer B & Thrall C (2004) Analysis of Ephedra alkaloids by gas Chromatography. LCGC North America. The Application Notebook Advertising Supplement, June 2004. p. 43.
113. World Anti-Doping Agency (2004) The World Anti-Doping Code. The 2004 Prohibited List International Standard. Montreal: WADA.
114. Ziegler PJ, Nelson JA & Jonnalagadda SS (2003) Use of dietary supplements by elite figure skaters. International Journal of Sport Nutrition and Exercise Metabolism 13, 266-276.
115. Zorpette G (1999) The mystery of muscle. Scientific American 10, 48-55.